IFC Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

IFC Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,180	Closed	-$251K	–	393
2015 Q3	$251K	Buy	+4,180	New	+$271K	0.04%	302

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

IFC Holdings's TEVA Position: Q4 2015 in Review

IFC Holdings sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 4,180 shares — an estimated $251K sold.

IFC Holdings first reported a position in TEVA in Q3 2015 and held it in 1 quarter. The position peaked at $251K in Q3 2015. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

IFC Holdings reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
IFC Holdings sold 4,180 Teva Pharmaceuticals shares in Q4 2015, an estimated $251K.
IFC Holdings first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 1 quarter.
IFC Holdings's Teva Pharmaceuticals position peaked at $251K in Q3 2015.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on IFC Holdings's 13F filing for Q4 2015, filed 3 Feb 2016.